Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Rigel Pharmaceutical Inc. buy Citigroup Inc.

Rigel Pharmaceutical Inc.
Start price
€1.40
07.03.24 / 50%
Target price
€3.67
07.03.25
Performance (%)
-47.24%
End price
-
08.03.25
Summary
This prediction is currently being closed. Massive losses of -47.24% have been the result for the BUY prediction by Citigroup_Inc_. Citigroup_Inc_ has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Rigel Pharmaceutical Inc. - - -
iShares Core DAX® 4.244% 2.864% 14.030%
iShares Nasdaq 100 4.890% 2.814% 32.707%
iShares Nikkei 225® 9.397% 7.826% 48.296%
iShares S&P 500 3.528% 1.950% 25.247%

Comments by Citigroup_Inc_ for this prediction

In the thread Rigel Pharmaceutical Inc. diskutieren
Prediction Buy
Perf. (%) -47.24%
Target price 3.665
Change
Ends at 07.03.25

Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) had its price target raised by analysts at Citigroup Inc. from $3.00 to $4.00. They now have a "buy" rating on the stock.
Ratings data for RIGL provided by MarketBeat

Citigroup Inc. 
0
Report Share
07.03.24
In the thread Trading Rigel Pharmaceutical Inc.
Prediction Buy
Perf. (%) -47.24%
Target price 3.665
Change
Ends at 07.03.25

Die von Citigroup_Inc_ gewählte maximale Laufzeit wurde überschritten

Citigroup Inc. 
0
Report Share
08.03.25

Stopped prediction by Citigroup_Inc_ for Rigel Pharmaceutical Inc.

buy
Rigel Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€0.74
06.03.25
€50.83
06.03.26
-
07.03.26

Citigroup Inc. 
06.03.25 50%
buy
Rigel Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€0.74
12.11.24
€46.15
12.11.25
-
13.11.25

Citigroup Inc. 
12.11.24 50%